\-\ Texto\\:\\ \ \(0\)\
\-\ complete\\ blood\\ count\\:\\ wbc\\ 30\\,400\\ \\(increased\\ pmns\\)\\;\\ hemoglobin\\ 13\\.9\\;\\ platelets\\ 436\\,000\ \(0\)\
\-\ basic\\ metabolic\\ panel\\ was\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ csf\\ analysis\\:\\ \\ glucose\\ 72mg\\/dl\\;\\ protein\\ 160\\ mg\\/dl\\;\\ myelin\\ basic\\ protein\\ 253\\ ng\\/ml\\ \\(0\\.07\\-4\\.10\\)\\;\\ rbc\\ 240\\ \\(87\\%\\ pmns\\)\\;\\ rbc\\ 54\\;\\ igg\\ level\\ 19\\.8\\ \\(0\\.0\\-6\\.0\\)\\;\\ oligocloncal\\ bands\\ were\\ absent\\.\ \(0\)\
\-\ no\\ evidence\\ for\\ haemophilus\\ influenzae\\ b\\,\\ streptococcus\\ pneumoniae\\,\\ vdrl\\,\\ afb\\,\\ hsv\\,\\ cmv\\,\\ arbovirus\\ \\(including\\ west\\ nile\\ virus\\)\\,\\ or\\ fungal\\ elements\\ in\\ the\\ csf\\ fluid\\.\\ \\ \ \(0\)\
\-\ multiple\\ blood\\ \\ and\\ fungal\\ cultures\\ were\\ negative\\.\\ \\ in\\ addition\\,\\ hiv\\,\\ enterovirus\\ pcr\\ \\,\\ and\\ tuberculin\\ skin\\ testing\\ was\\ negative\\.\\ \\ a\\ 2\\-d\\ transthoracic\\ echocardiogram\\ \\ was\\ without\\ evidence\\ of\\ valvular\\ vegetations\\.\ \(0\)\
\-\ this\\ patient\\ received\\ high\\ dose\\ steroids\\ for\\ five\\ days\\ and\\ his\\ condition\\ completely\\ resolved\\.\ \(0\)\
\-\ diffuse\\ patchy\\ areas\\ of\\ abnormal\\ signal\\ intensity\\ involving\\ the\\ gray\\ and\\ white\\ matter\\ on\\ t2w\\ and\\ flair\\ sequences\\,\\ no\\ enhancement\\ and\\ no\\ mass\\ effect\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ acute\\ presentation\\ of\\ multiple\\ sclerosis\ \(0\)\
\-\ neoplastic\\ \ \(96\)\
\-\ embolic\\ stroke\ \(4\)\
\-\ abscesses\ \(65\)\
\-\ a\\ 33\\ year\\ old\\ man\\ presented\\ to\\ his\\ primary\\ medical\\ doctor\\ complaining\\ of\\ diarrhea\\,\\ vomiting\\,\\ and\\ fevers\\ up\\ to\\ 39\\.0\\?\\ c\\.\\ \\ he\\ denied\\ bloody\\ bowel\\ movements\\,\\ sick\\ contacts\\,\\ recent\\ antibiotics\\,\\ suspicion\\ of\\ food\\ poisoning\\.\\ \\ he\\ was\\ diagnosed\\ with\\ a\\ gastroenteritis\\.\\ \\ over\\ the\\ subsequent\\ 2\\-3\\ days\\,\\ his\\ gastrointestinal\\ symptoms\\ resolved\\;\\ however\\,\\ he\\ continued\\ to\\ have\\ fevers\\.\\ \\ over\\ the\\ next\\ week\\,\\ he\\ developed\\ worsening\\ headaches\\.\\ \\ he\\ would\\ occasionally\\ see\\ spots\\ throughout\\ his\\ visual\\ fields\\.\\ \\ he\\ complained\\ of\\ having\\ difficulty\\ moving\\ the\\ entire\\ right\\ side\\ of\\ his\\ body\\ and\\ found\\ himself\\ tripping\\ over\\ his\\ own\\ feet\\ quite\\ frequently\\.\\ \\ in\\ addition\\,\\ he\\ was\\ experiencing\\ difficulty\\ reading\\ complaining\\,\\ \\‚\\Ä\\úthe\\ words\\ seemed\\ jumbled\\.\\‚\\Ä\\ù\\ \\ ten\\ days\\ after\\ presentation\\ to\\ his\\ primary\\ medical\\ doctor\\,\\ he\\ awakened\\ his\\ wife\\ screaming\\ out\\ with\\ violent\\ thrashing\\.\\ \\ he\\ began\\ to\\ have\\ tonic\\-clonic\\ seizure\\ activity\\ with\\ bowel\\ and\\ bladder\\ incontinence\\.\\ \\ his\\ wife\\ called\\ ems\\.\\ \\ en\\ route\\ to\\ the\\ emergency\\ department\\,\\ he\\ continued\\ to\\ manifest\\ combative\\ behavior\\.\\ \\ three\\ additional\\ seizures\\ were\\ witnessed\\.\\ \\ he\\ was\\ intubated\\ and\\ sedated\\ for\\ airway\\ protection\\.\ \(0\)\
\-\ this\\ case\\ is\\ slightly\\ atypical\\ in\\ that\\ predominantly\\ adem\\ affects\\ the\\ white\\ matter\\ exclusively\\;\\ in\\ this\\ case\\ it\\ has\\ also\\ affected\\ the\\ gray\\ matter\\.\\ \ \(0\)\
\-\ given\\ the\\ patient\\'s\\ recent\\ history\\ of\\ viral\\ illness\\,\\ the\\ findings\\ are\\ most\\ consistent\\ with\\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\\.\\ \\ there\\ is\\ no\\ evidence\\ of\\ intracranial\\ hemorrhage\\.\ \(0\)\
\-\ adem\\ usually\\ occurs\\ one\\ to\\ four\\ weeks\\ after\\ an\\ offending\\ agent\\.\\ \\ viral\\ etiologies\\ include\\ measles\\,\\ mumps\\,\\ influenza\\ a\\ and\\ b\\,\\ hepatitis\\ a\\ and\\ b\\,\\ hsv\\,\\ hhv\\-6\\,\\ \\ rubella\\,\\ cmv\\,\\ ebv\\,\\ and\\ varicella\\,\\ which\\ is\\ the\\ most\\ common\\.\\ \\ bacterial\\ etiologies\\ include\\ chlamydia\\,\\ legionella\\,\\ campylobacter\\,\\ and\\ most\\ commonly\\ mycoplasma\\ pneumonia\\.\\ \\ post\\-vaccination\\ etiologies\\ include\\ rabies\\,\\ dtp\\,\\ smallpox\\,\\ measles\\,\\ japanese\\ b\\ encephalitis\\,\\ polio\\,\\ hepatitis\\ b\\,\\ and\\ influenza\\.\\ \\ there\\ is\\ a\\ sensitization\\ of\\ peripheral\\ lymphocytes\\ to\\ neural\\ tissue\\ resulting\\ in\\ an\\ inflammatory\\ response\\ directed\\ against\\ neuronal\\ antigens3\\.\\ \\ the\\ exact\\ incidence\\ is\\ not\\ known\\;\\ and\\ often\\ times\\ the\\ offending\\ agent\\ is\\ never\\ identified\\.\\ initial\\ symptoms\\ include\\:\\ low\\ grade\\ fevers\\,\\ headache\\,\\ meningismus\\,\\ drowsiness\\ and\\ \\ cranial\\ nerve\\ palsies\\.\\ \\ there\\ is\\ a\\ progression\\ \\ of\\ symptoms\\ to\\ stupor\\,\\ seizures\\,\\ coma\\,\\ multifocal\\ neurologic\\ signs\\,\\ visual\\ difficulties\\,\\ hemiparesis\\ or\\ paraparesis\\,\\ ataxia\\ and\\ signs\\ of\\ encephalopathy\\ followed\\ by\\ hyperreflexia\\ and\\ spasticity\\.\\ \\ this\\ is\\ a\\ monophasic\\ illness\\ with\\ recovery\\ evident\\ within\\ a\\ few\\ days\\.\\ \\ \ \(0\)\
\-\ diagnosis\\ of\\ adem\\ is\\ largely\\ established\\ with\\ neuroimaging\\.\\ \\ mri\\ demonstrates\\ 1\\)\\ scattered\\ lesions\\ predominately\\ throughout\\ the\\ white\\ matter\\;\\ \\ 2\\)\\ increased\\ intensity\\ on\\ t2\\-weighted\\ imaging\\ and\\ flair\\;\\ \\ 3\\)\\ extensive\\ perifocal\\ edema\\;\\ 4\\)\\ sparing\\ of\\ the\\ corpus\\ collosum\\ 5\\)\\ and\\ lesions\\ of\\ the\\ same\\ age\\ and\\ without\\ the\\ appearance\\ of\\ new\\ lesions\\ after\\ the\\ initial\\ study5\\.\\ \\ csf\\ analysis\\ typically\\ shows\\ normal\\ to\\ increase\\ opening\\ pressure\\,\\ lymphocytic\\ pleocytosis\\,\\ elevated\\ protein\\,\\ normal\\ glucose\\,\\ increased\\ igg\\,\\ increased\\ mbp\\,\\ and\\ absence\\ of\\ oligoclonal\\ banding\\.\ \(0\)\
\-\ the\\ images\\ shown\\ in\\ this\\ case\\ were\\ 6\\ days\\ after\\ seizure\\ activity\\.\\ this\\ case\\ was\\ slightly\\ atypical\\ in\\ which\\ there\\ was\\ some\\ gray\\ matter\\ involvement\\ as\\ well\\.\\ \\ conventional\\ adem\\ affects\\ the\\ white\\ matter\\ exclusively\\;\\ though\\,\\ it\\ can\\ affect\\ both\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\;\\:\\ 0\\.039252348613422354\ \(0\)\
\-\ he\\:\\ 0\\.033883799434577797\ \(0\)\
\-\ adem\\:\\ 0\\.03328137453382979\ \(0\)\
\-\ his\\:\\ 0\\.028638244507522465\ \(0\)\
\-\ matter\\:\\ 0\\.026081240080626338\ \(0\)\
\-\ b\\:\\ 0\\.026020844193698014\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.022187891358946443\ \(0\)\
\-\ \\,\\:\\ 0\\.020985276396688943\ \(0\)\
\-\ disseminated\\:\\ 0\\.02017287019892354\ \(0\)\
\-\ etiologies\\:\\ 0\\.01836426736457666\ \(0\)\
\-\ measles\\:\\ 0\\.017750925774964302\ \(0\)\
\-\ pmns\\:\\ 0\\.0174058834167614\ \(0\)\
\-\ protein\\:\\ 0\\.016994967539237148\ \(0\)\
\-\ days\\:\\ 0\\.01691908460059417\ \(0\)\
\-\ wife\\:\\ 0\\.016829285092952073\ \(0\)\
\-\ offending\\:\\ 0\\.016829285092952073\ \(0\)\
\-\ influenza\\:\\ 0\\.016829285092952073\ \(0\)\
\-\ gray\\:\\ 0\\.01620461021603435\ \(0\)\
\-\ hsv\\:\\ 0\\.015959847789021292\ \(0\)\
\-\ fevers\\:\\ 0\\.015743907879302844\ \(0\)\
\-\ igg\\:\\ 0\\.015170747919379996\ \(0\)\
\-\ exclusively\\:\\ 0\\.015038207107009063\ \(0\)\
\-\ white\\:\\ 0\\.014646533399028517\ \(0\)\
\-\ cmv\\:\\ 0\\.01416876980307828\ \(0\)\
\-\ agent\\:\\ 0\\.01416876980307828\ \(0\)\
\-\ basic\\:\\ 0\\.014078094558087917\ \(0\)\
\-\ csf\\:\\ 0\\.01383137345661245\ \(0\)\
\-\ doctor\\:\\ 0\\.013379669933436984\ \(0\)\
\-\ rbc\\:\\ 0\\.012722734175338169\ \(0\)\
\-\ hepatitis\\:\\ 0\\.012670530797256723\ \(0\)\
\-\ affects\\:\\ 0\\.01256918528523274\ \(0\)\
\-\ include\\:\\ 0\\.01238839011901957\ \(0\)\
\-\ illness\\:\\ 0\\.012287016572144907\ \(0\)\
\-\ case\\:\\ 0\\.0120769020211064\ \(0\)\
\-\ glucose\\:\\ 0\\.011801093493325941\ \(0\)\
\-\ 30\\,400\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 436\\,000\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 72mg\\/dl\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 253\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 0\\.07\\-4\\.10\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ oligocloncal\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ arbovirus\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 2\\-d\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ 39\\.0\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ jumbled\\.\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ thrashing\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ mumps\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ dtp\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ antigens3\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ study5\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ mbp\\:\\ 0\\.011389558687295218\ \(0\)\
\-\ analysis\\:\\ 0\\.011239303114501073\ \(0\)\
\-\ viral\\:\\ 0\\.011123149657492632\ \(0\)\
\-\ acute\\:\\ 0\\.010903769142669226\ \(0\)\
\-\ increased\\:\\ 0\\.01080353892402923\ \(0\)\
\-\ complaining\\:\\ 0\\.01077810729928973\ \(0\)\
\-\ fungal\\:\\ 0\\.010704624262285767\ \(0\)\
\-\ resolved\\:\\ 0\\.010704624262285767\ \(0\)\
\-\ 240\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ 0\\.0\\-6\\.0\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ vdrl\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ enterovirus\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ post\\-vaccination\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ rabies\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ smallpox\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ sensitization\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ paraparesis\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ perifocal\\:\\ 0\\.010494019694323712\ \(0\)\
\-\ was\\:\\ 0\\.010214754751562655\ \(0\)\
\-\ \\)\\:\\ 0\\.010140716554581855\ \(0\)\
\-\ flair\\:\\ 0\\.010123200578851646\ \(0\)\
\-\ were\\:\\ 0\\.010027319569456957\ \(0\)\
\-\ visual\\:\\ 0\\.010010015507382931\ \(0\)\
\-\ influenzae\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ tuberculin\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ awakened\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ screaming\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ combative\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ hhv\\-6\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ polio\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ drowsiness\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ stupor\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ banding\\:\\ 0\\.009970162965501794\ \(0\)\
\-\ difficulty\\:\\ 0\\.009831739353669877\ \(0\)\
\-\ seizure\\:\\ 0\\.00976373597300483\ \(0\)\
\-\ vegetations\\:\\ 0\\.009598480701352207\ \(0\)\
\-\ tripping\\:\\ 0\\.009598480701352207\ \(0\)\
\-\ violent\\:\\ 0\\.009598480701352207\ \(0\)\
\-\ campylobacter\\:\\ 0\\.009598480701352207\ \(0\)\
\-\ pleocytosis\\:\\ 0\\.009598480701352207\ \(0\)\
\-\ atypical\\:\\ 0\\.009569846603643295\ \(0\)\
\-\ continued\\:\\ 0\\.009508320379628519\ \(0\)\
\-\ seizures\\:\\ 0\\.0094931650322063\ \(0\)\
\-\ addition\\:\\ 0\\.00936062421983537\ \(0\)\
\-\ 19\\.8\\:\\ 0\\.009310181539447543\ \(0\)\
\-\ haemophilus\\:\\ 0\\.009310181539447543\ \(0\)\
\-\ tonic\\-clonic\\:\\ 0\\.009310181539447543\ \(0\)\
\-\ japanese\\:\\ 0\\.009310181539447543\ \(0\)\
\-\ meningismus\\:\\ 0\\.009310181539447543\ \(0\)\
\-\ after\\:\\ 0\\.009136957119427403\ \(0\)\
\-\ protection\\:\\ 0\\.009074623972530288\ \(0\)\
\-\ monophasic\\:\\ 0\\.009074623972530288\ \(0\)\
\-\ slightly\\:\\ 0\\.008925649246142307\ \(0\)\
\-\ 13\\.9\\:\\ 0\\.008875462887482151\ \(0\)\
\-\ nile\\:\\ 0\\.008875462887482151\ \(0\)\
\-\ transthoracic\\:\\ 0\\.008875462887482151\ \(0\)\
\-\ lesions\\:\\ 0\\.008866513590480418\ \(0\)\
\-\ rubella\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ chlamydia\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ legionella\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ palsies\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ spasticity\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ collosum\\:\\ 0\\.0087029417083807\ \(0\)\
\-\ this\\:\\ 0\\.008692455417569678\ \(0\)\
\-\ evidence\\:\\ 0\\.008683885982042162\ \(0\)\
\-\ myelin\\:\\ 0\\.00855076724370837\ \(0\)\
\-\ reading\\:\\ 0\\.00855076724370837\ \(0\)\
\-\ sedated\\:\\ 0\\.00855076724370837\ \(0\)\
\-\ varicella\\:\\ 0\\.00855076724370837\ \(0\)\
\-\ over\\:\\ 0\\.008432723217596754\ \(0\)\
\-\ words\\:\\ 0\\.008414642546476036\ \(0\)\
\-\ oligoclonal\\:\\ 0\\.008414642546476036\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.008291502779286987\ \(0\)\
\-\ mycoplasma\\:\\ 0\\.008291502779286987\ \(0\)\
\-\ activity\\:\\ 0\\.008284358213905784\ \(0\)\
\-\ throughout\\:\\ 0\\.008265496967183273\ \(0\)\
\-\ symptoms\\:\\ 0\\.008254486344566431\ \(0\)\
\-\ 160\\:\\ 0\\.008179084979558783\ \(0\)\
\-\ pcr\\:\\ 0\\.008179084979558783\ \(0\)\
\-\ witnessed\\:\\ 0\\.008179084979558783\ \(0\)\
\-\ hyperreflexia\\:\\ 0\\.008179084979558783\ \(0\)\
\-\ west\\:\\ 0\\.008075670628559382\ \(0\)\
\-\ sick\\:\\ 0\\.008075670628559382\ \(0\)\
\-\ himself\\:\\ 0\\.008075670628559382\ \(0\)\
\-\ en\\:\\ 0\\.008075670628559382\ \(0\)\
\-\ intensity\\:\\ 0\\.00798106117927468\ \(0\)\
\-\ route\\:\\ 0\\.007979923894510646\ \(0\)\
\-\ behavior\\:\\ 0\\.007979923894510646\ \(0\)\
\-\ ebv\\:\\ 0\\.007979923894510646\ \(0\)\
\-\ poisoning\\:\\ 0\\.007890785817654119\ \(0\)\
\-\ seemed\\:\\ 0\\.007890785817654119\ \(0\)\
\-\ ems\\:\\ 0\\.007807402715409195\ \(0\)\
\-\ neuronal\\:\\ 0\\.007807402715409195\ \(0\)\
\-\ signs\\:\\ 0\\.007770997245442002\ \(0\)\
\-\ afb\\:\\ 0\\.0077290763306334396\ \(0\)\
\-\ valvular\\:\\ 0\\.0077290763306334396\ \(0\)\
\-\ spots\\:\\ 0\\.0077290763306334396\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.0077290763306334396\ \(0\)\
\-\ ten\\:\\ 0\\.007655228250736865\ \(0\)\
\-\ most\\:\\ 0\\.007646647836155334\ \(0\)\
\-\ presentation\\:\\ 0\\.007605686394033805\ \(0\)\
\-\ gastroenteritis\\:\\ 0\\.007585373959689998\ \(0\)\
\-\ manifest\\:\\ 0\\.007585373959689998\ \(0\)\
\-\ 87\\:\\ 0\\.007519103553504531\ \(0\)\
\-\ contacts\\:\\ 0\\.007456067165688728\ \(0\)\
\-\ recent\\:\\ 0\\.007423046637828934\ \(0\)\
\-\ streptococcus\\:\\ 0\\.007395963786315482\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.0073385325685237065\ \(0\)\
\-\ initial\\:\\ 0\\.007316749724235939\ \(0\)\
\-\ virus\\:\\ 0\\.0072308043915998675\ \(0\)\
\-\ platelets\\:\\ 0\\.007180131635587876\ \(0\)\
\-\ largely\\:\\ 0\\.007180131635587876\ \(0\)\
\-\ bloody\\:\\ 0\\.007131371521914948\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.007131371521914948\ \(0\)\
\-\ difficulties\\:\\ 0\\.007131371521914948\ \(0\)\
\-\ own\\:\\ 0\\.00708438490153914\ \(0\)\
\-\ predominately\\:\\ 0\\.00708438490153914\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.007039047279043959\ \(0\)\
\-\ coma\\:\\ 0\\.0069528827125082075\ \(0\)\
\-\ bowel\\:\\ 0\\.006924944529417983\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.006872107057493563\ \(0\)\
\-\ exact\\:\\ 0\\.006833537337661934\ \(0\)\
\-\ opening\\:\\ 0\\.006833537337661934\ \(0\)\
\-\ experiencing\\:\\ 0\\.006796085739634476\ \(0\)\
\-\ medical\\:\\ 0\\.006794082170713189\ \(0\)\
\-\ moving\\:\\ 0\\.0067596892577653596\ \(0\)\
\-\ established\\:\\ 0\\.0067596892577653596\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.006724290066307847\ \(0\)\
\-\ embolic\\:\\ 0\\.006724290066307847\ \(0\)\
\-\ quite\\:\\ 0\\.0066562749067659585\ \(0\)\
\-\ negative\\:\\ 0\\.006594625739986756\ \(0\)\
\-\ bands\\:\\ 0\\.006591661960287068\ \(0\)\
\-\ directed\\:\\ 0\\.006591661960287068\ \(0\)\
\-\ there\\:\\ 0\\.006572173418423715\ \(0\)\
\-\ intubated\\:\\ 0\\.006560528172717222\ \(0\)\
\-\ sparing\\:\\ 0\\.006560528172717222\ \(0\)\
\-\ primary\\:\\ 0\\.006541044606965624\ \(0\)\
\-\ is\\:\\ 0\\.00653826486493867\ \(0\)\
\-\ echocardiogram\\:\\ 0\\.0065301270132725265\ \(0\)\
\-\ incontinence\\:\\ 0\\.0065301270132725265\ \(0\)\
\-\ panel\\:\\ 0\\.006500424793343976\ \(0\)\
\-\ never\\:\\ 0\\.006500424793343976\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.006500424793343976\ \(0\)\
\-\ c\\.\\:\\ 0\\.006388006993615772\ \(0\)\
\-\ food\\:\\ 0\\.006388006993615772\ \(0\)\
\-\ affect\\:\\ 0\\.006361367087669084\ \(0\)\
\-\ conventional\\:\\ 0\\.006259982571594803\ \(0\)\
\-\ abscesses\\:\\ 0\\.006235832528943442\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.006212125631439312\ \(0\)\
\-\ t2w\\:\\ 0\\.006188845908567634\ \(0\)\
\-\ against\\:\\ 0\\.006188845908567634\ \(0\)\
\-\ encephalitis\\:\\ 0\\.006165978237896574\ \(0\)\
\-\ airway\\:\\ 0\\.006143508286072454\ \(0\)\
\-\ hiv\\:\\ 0\\.006121422454858887\ \(0\)\
\-\ to\\:\\ 0\\.0060694434016445075\ \(0\)\
\-\ elements\\:\\ 0\\.006057343719536702\ \(0\)\
\-\ blood\\:\\ 0\\.006026901996148061\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.006016324729466184\ \(0\)\
\-\ fields\\:\\ 0\\.006016324729466184\ \(0\)\
\-\ recovery\\:\\ 0\\.006016324729466184\ \(0\)\
\-\ movements\\:\\ 0\\.005996293480711706\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.005957139282397329\ \(0\)\
\-\ multifocal\\:\\ 0\\.005937998344690428\ \(0\)\
\-\ patchy\\:\\ 0\\.005919136846730282\ \(0\)\
\-\ ataxia\\:\\ 0\\.005900546746662971\ \(0\)\
\-\ 54\\:\\ 0\\.005828751073336341\ \(0\)\
\-\ complained\\:\\ 0\\.005828751073336341\ \(0\)\
\-\ occasionally\\:\\ 0\\.005811408669806445\ \(0\)\
\-\ called\\:\\ 0\\.005794295973746986\ \(0\)\
\-\ dose\\:\\ 0\\.00577740697947392\ \(0\)\
\-\ stroke\\:\\ 0\\.005760735913794454\ \(0\)\
\-\ 33\\:\\ 0\\.00572802556756152\ \(0\)\
\-\ diarrhea\\:\\ 0\\.00572802556756152\ \(0\)\
\-\ suspicion\\:\\ 0\\.00572802556756152\ \(0\)\
\-\ cultures\\:\\ 0\\.005680462294793152\ \(0\)\
\-\ neoplastic\\:\\ 0\\.005649699182785765\ \(0\)\
\-\ feet\\:\\ 0\\.005649699182785765\ \(0\)\
\-\ bacterial\\:\\ 0\\.005649699182785765\ \(0\)\
\-\ next\\:\\ 0\\.00560488580037247\ \(0\)\
\-\ \\(\\:\\ 0\\.005599703304215973\ \(0\)\
\-\ began\\:\\ 0\\.0055902868917756575\ \(0\)\
\-\ neural\\:\\ 0\\.0055902868917756575\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.0055902868917756575\ \(0\)\
\-\ response\\:\\ 0\\.0055334869907147834\ \(0\)\
\-\ five\\:\\ 0\\.0055059968118423225\ \(0\)\
\-\ progression\\:\\ 0\\.005492468000644266\ \(0\)\
\-\ metabolic\\:\\ 0\\.00545271133570014\ \(0\)\
\-\ corpus\\:\\ 0\\.005439726405656856\ \(0\)\
\-\ entire\\:\\ 0\\.00542687068104036\ \(0\)\
\-\ denied\\:\\ 0\\.005376690017841053\ \(0\)\
\-\ times\\:\\ 0\\.005352312131142884\ \(0\)\
\-\ and\\:\\ 0\\.0053491048215000316\ \(0\)\
\-\ testing\\:\\ 0\\.005340293535971936\ \(0\)\
\-\ completely\\:\\ 0\\.005304894344514425\ \(0\)\
\-\ without\\:\\ 0\\.005199000429866047\ \(0\)\
\-\ steroids\\:\\ 0\\.005193446871278756\ \(0\)\
\-\ normal\\:\\ 0\\.00519229633565543\ \(0\)\
\-\ predominantly\\:\\ 0\\.005172266238493644\ \(0\)\
\-\ scattered\\:\\ 0\\.005141132450923799\ \(0\)\
\-\ received\\:\\ 0\\.0051309190407078905\ \(0\)\
\-\ though\\:\\ 0\\.005120785736494679\ \(0\)\
\-\ having\\:\\ 0\\.005071278159876931\ \(0\)\
\-\ incidence\\:\\ 0\\.005061600289425823\ \(0\)\
\-\ evident\\:\\ 0\\.005051994374067273\ \(0\)\
\-\ few\\:\\ 0\\.004968611271822349\ \(0\)\
\-\ it\\:\\ 0\\.0049634325181731696\ \(0\)\
\-\ department\\:\\ 0\\.004950790442194008\ \(0\)\
\-\ in\\:\\ 0\\.0048999677923285455\ \(0\)\
\-\ resulting\\:\\ 0\\.004848738231188025\ \(0\)\
\-\ count\\:\\ 0\\.004800583974344057\ \(0\)\
\-\ cranial\\:\\ 0\\.004800583974344057\ \(0\)\
\-\ four\\:\\ 0\\.004792729909645889\ \(0\)\
\-\ absent\\:\\ 0\\.0047849233018216475\ \(0\)\
\-\ frequently\\:\\ 0\\.0047849233018216475\ \(0\)\
\-\ have\\:\\ 0\\.004781493742545457\ \(0\)\
\-\ affected\\:\\ 0\\.004777163580813622\ \(0\)\
\-\ intracranial\\:\\ 0\\.00466603583577481\ \(0\)\
\-\ multiple\\:\\ 0\\.00465066150769837\ \(0\)\
\-\ increase\\:\\ 0\\.004631020422625209\ \(0\)\
\-\ condition\\:\\ 0\\.004617275722101881\ \(0\)\
\-\ a\\:\\ 0\\.004611625602541875\ \(0\)\
\-\ sequences\\:\\ 0\\.004610457818870817\ \(0\)\
\-\ neurologic\\:\\ 0\\.004610457818870817\ \(0\)\
\-\ absence\\:\\ 0\\.00459021735796074\ \(0\)\
\-\ pneumonia\\:\\ 0\\.004563714076522622\ \(0\)\
\-\ limits\\:\\ 0\\.004550663564912153\ \(0\)\
\-\ same\\:\\ 0\\.004550663564912153\ \(0\)\
\-\ occurs\\:\\ 0\\.004531331688068855\ \(0\)\
\-\ bladder\\:\\ 0\\.0044811510248695475\ \(0\)\
\-\ no\\:\\ 0\\.004446739796918874\ \(0\)\
\-\ additional\\:\\ 0\\.00442693371337209\ \(0\)\
\-\ shown\\:\\ 0\\.00442693371337209\ \(0\)\
\-\ extensive\\:\\ 0\\.004415188271897604\ \(0\)\
\-\ \\:\\:\\ 0\\.004380910139498702\ \(0\)\
\-\ worsening\\:\\ 0\\.0043468733467710565\ \(0\)\
\-\ pressure\\:\\ 0\\.0043358306328454\ \(0\)\
\-\ \\?\\:\\ 0\\.004308629845768097\ \(0\)\
\-\ subsequent\\:\\ 0\\.00429790787830725\ \(0\)\
\-\ developed\\:\\ 0\\.004250730600561647\ \(0\)\
\-\ skin\\:\\ 0\\.004240476660515476\ \(0\)\
\-\ headaches\\:\\ 0\\.004220209740402168\ \(0\)\
\-\ vomiting\\:\\ 0\\.0042151922985075975\ \(0\)\
\-\ within\\:\\ 0\\.004212225861462743\ \(0\)\
\-\ grade\\:\\ 0\\.004205215494768696\ \(0\)\
\-\ emergency\\:\\ 0\\.004180605423747126\ \(0\)\
\-\ commonly\\:\\ 0\\.004166061296454317\ \(0\)\
\-\ antibiotics\\:\\ 0\\.004146920358747417\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.004123386198681085\ \(0\)\
\-\ which\\:\\ 0\\.004121820638869635\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.0041002730659281455\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004059683665109826\ \(0\)\
\-\ involvement\\:\\ 0\\.0040464323729041555\ \(0\)\
\-\ wbc\\:\\ 0\\.004024644509787871\ \(0\)\
\-\ peripheral\\:\\ 0\\.003994745894075087\ \(0\)\
\-\ including\\:\\ 0\\.003986328993530909\ \(0\)\
\-\ nerve\\:\\ 0\\.003977966571689026\ \(0\)\
\-\ sclerosis\\:\\ 0\\.003965523557398379\ \(0\)\
\-\ identified\\:\\ 0\\.003945047856829873\ \(0\)\
\-\ would\\:\\ 0\\.003928897775739134\ \(0\)\
\-\ effect\\:\\ 0\\.003908989991045536\ \(0\)\
\-\ typically\\:\\ 0\\.0038971909166743827\ \(0\)\
\-\ complete\\:\\ 0\\.003885498622721001\ \(0\)\
\-\ involving\\:\\ 0\\.003873911193802705\ \(0\)\
\-\ new\\:\\ 0\\.0038472712878560187\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0038285735713075243\ \(0\)\
\-\ side\\:\\ 0\\.003824866281348929\ \(0\)\
\-\ headache\\:\\ 0\\.003791970849568215\ \(0\)\
\-\ given\\:\\ 0\\.0037847731169461793\ \(0\)\
\-\ the\\:\\ 0\\.0037509495849820953\ \(0\)\
\-\ week\\:\\ 0\\.003749373925488667\ \(0\)\
\-\ elevated\\:\\ 0\\.0037458867717817352\ \(0\)\
\-\ three\\:\\ 0\\.0037217367291303752\ \(0\)\
\-\ areas\\:\\ 0\\.0037149188258993114\ \(0\)\
\-\ followed\\:\\ 0\\.003701390014701255\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0036747501087545683\ \(0\)\
\-\ out\\:\\ 0\\.0036486484197138453\ \(0\)\
\-\ body\\:\\ 0\\.003585612031898042\ \(0\)\
\-\ often\\:\\ 0\\.003522575644082238\ \(0\)\
\-\ known\\:\\ 0\\.003493606052278837\ \(0\)\
\-\ found\\:\\ 0\\.0034793612589820574\ \(0\)\
\-\ age\\:\\ 0\\.0033603492578091814\ \(0\)\
\-\ usually\\:\\ 0\\.0033526204830319887\ \(0\)\
\-\ some\\:\\ 0\\.0033526204830319887\ \(0\)\
\-\ diffuse\\:\\ 0\\.003342386848030123\ \(0\)\
\-\ as\\:\\ 0\\.003339993555281984\ \(0\)\
\-\ 6\\:\\ 0\\.003297312869993378\ \(0\)\
\-\ see\\:\\ 0\\.0032948542780733697\ \(0\)\
\-\ 5\\:\\ 0\\.0032301814243464646\ \(0\)\
\-\ level\\:\\ 0\\.0031820271675024963\ \(0\)\
\-\ appearance\\:\\ 0\\.00315750203712486\ \(0\)\
\-\ abnormal\\:\\ 0\\.003148697984902986\ \(0\)\
\-\ fluid\\:\\ 0\\.003137776620935211\ \(0\)\
\-\ weeks\\:\\ 0\\.003133433794445928\ \(0\)\
\-\ edema\\:\\ 0\\.00312264016722389\ \(0\)\
\-\ 4\\:\\ 0\\.003076191091962591\ \(0\)\
\-\ however\\:\\ 0\\.0030741189348799363\ \(0\)\
\-\ low\\:\\ 0\\.003069984564426873\ \(0\)\
\-\ an\\:\\ 0\\.003053397582131085\ \(0\)\
\-\ shows\\:\\ 0\\.0030353665371174146\ \(0\)\
\-\ high\\:\\ 0\\.003021377339892527\ \(0\)\
\-\ presented\\:\\ 0\\.0030095059884010455\ \(0\)\
\-\ one\\:\\ 0\\.002991901012029256\ \(0\)\
\-\ up\\:\\ 0\\.0029687947688039062\ \(0\)\
\-\ enhancement\\:\\ 0\\.0029592878115284704\ \(0\)\
\-\ signal\\:\\ 0\\.0029109487471224533\ \(0\)\
\-\ common\\:\\ 0\\.0028892341239746735\ \(0\)\
\-\ for\\:\\ 0\\.0028260005761345545\ \(0\)\
\-\ both\\:\\ 0\\.0028193798329278056\ \(0\)\
\-\ consistent\\:\\ 0\\.0027071037065002626\ \(0\)\
\-\ 1\\:\\ 0\\.0026270366511107327\ \(0\)\
\-\ tissue\\:\\ 0\\.002616823240894824\ \(0\)\
\-\ man\\:\\ 0\\.0026110230530878545\ \(0\)\
\-\ or\\:\\ 0\\.0025879140800095803\ \(0\)\
\-\ imaging\\:\\ 0\\.0025866586879271353\ \(0\)\
\-\ 3\\:\\ 0\\.0025852396985872605\ \(0\)\
\-\ \\%\\:\\ 0\\.002575350172281664\ \(0\)\
\-\ of\\:\\ 0\\.0025588690097749396\ \(0\)\
\-\ mri\\:\\ 0\\.0025365321122927907\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0025351670940315504\ \(0\)\
\-\ can\\:\\ 0\\.002504163246084069\ \(0\)\
\-\ well\\:\\ 0\\.0024975206110706086\ \(0\)\
\-\ \\'s\\:\\ 0\\.002434168757580162\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0024116552992935222\ \(0\)\
\-\ 2\\:\\ 0\\.0023773959903237033\ \(0\)\
\-\ findings\\:\\ 0\\.0023499185216924543\ \(0\)\
\-\ patient\\:\\ 0\\.0022134158421612095\ \(0\)\
\-\ also\\:\\ 0\\.0021765111029330123\ \(0\)\
\-\ images\\:\\ 0\\.0021179120051025247\ \(0\)\
\-\ has\\:\\ 0\\.0020732557758324005\ \(0\)\
\-\ that\\:\\ 0\\.0019069518456832344\ \(0\)\
\-\ on\\:\\ 0\\.001870519411796972\ \(0\)\
\-\ by\\:\\ 0\\.0018383345003163756\ \(0\)\
\-\ \\.\\:\\ 0\\.0017887363149825643\ \(0\)\
\-\ not\\:\\ 0\\.0015953729609068934\ \(0\)\
\-\ mass\\:\\ 0\\.0015354793371415562\ \(0\)\
\-\ history\\:\\ 0\\.0015248249841176788\ \(0\)\
\-\ are\\:\\ 0\\.0015050050032682193\ \(0\)\
\-\ year\\:\\ 0\\.0012352781256756004\ \(0\)\
\-\ right\\:\\ 0\\.0011648988489798666\ \(0\)\
\-\ old\\:\\ 0\\.0011304064558943859\ \(0\)\
\-\ with\\:\\ 0\\.0009070091169758894\ \(0\)\
